These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

460 related items for PubMed ID: 33591026

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. COVID-19 Vaccination-Related Uptake on FDG PET/CT: An Emerging Dilemma and Suggestions for Management.
    McIntosh LJ, Bankier AA, Vijayaraghavan GR, Licho R, Rosen MP.
    AJR Am J Roentgenol; 2021 Oct; 217(4):975-983. PubMed ID: 33646823
    [Abstract] [Full Text] [Related]

  • 5. FDG PET/CT radiomics as a tool to differentiate between reactive axillary lymphadenopathy following COVID-19 vaccination and metastatic breast cancer axillary lymphadenopathy: a pilot study.
    Eifer M, Pinian H, Klang E, Alhoubani Y, Kanana N, Tau N, Davidson T, Konen E, Catalano OA, Eshet Y, Domachevsky L.
    Eur Radiol; 2022 Sep; 32(9):5921-5929. PubMed ID: 35385985
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Reactive Axillary Lymphadenopathy to COVID-19 Vaccination on 18F-FDG PET/CT.
    Smith MV, Yang M.
    J Nucl Med Technol; 2021 Sep; 49(3):286-287. PubMed ID: 33820864
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Evolving Bilateral Hypermetabolic Axillary Lymphadenopathy on FDG PET/CT Following 2-Dose COVID-19 Vaccination.
    Weeks JK, O'Brien SR, Rosenspire KC, Dubroff JG, Pantel AR.
    Clin Nucl Med; 2021 Dec 01; 46(12):1011-1012. PubMed ID: 34735411
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A sigh of relief: vaccine-associated hypermetabolic lymphadenopathy following the third COVID-19 vaccine dose is short in duration and uncommonly interferes with the interpretation of [18F]FDG PET-CT studies performed in oncologic patients.
    Cohen D, Hazut Krauthammer S, Wolf I, Even-Sapir E.
    Eur J Nucl Med Mol Imaging; 2022 Mar 01; 49(4):1338-1344. PubMed ID: 34651230
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Axillary lymph node characteristics in breast cancer patients versus post-COVID-19 vaccination: Overview of current evidence per imaging modality.
    van Nijnatten TJA, Jochelson MS, Lobbes MBI.
    Eur J Radiol; 2022 Jul 01; 152():110334. PubMed ID: 35512513
    [Abstract] [Full Text] [Related]

  • 17. Radiation Recall Pneumonitis on FDG PET/CT Triggered by COVID-19 Vaccination.
    Hughes NM, Hammer MM, Awad MM, Jacene HA.
    Clin Nucl Med; 2022 Mar 01; 47(3):e281-e283. PubMed ID: 34739397
    [Abstract] [Full Text] [Related]

  • 18. DOTATATE Uptake in an Axillary Lymph Node After COVID-19 Vaccination.
    Brophy J, Henkle G, Rohren EM.
    Clin Nucl Med; 2022 Feb 01; 47(2):174-175. PubMed ID: 34269723
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Oxford-AstraZeneca COVID-19 vaccination induced lymphadenopathy on [18F]Choline PET/CT-not only an FDG finding.
    Nawwar AA, Searle J, Singh R, Lyburn ID.
    Eur J Nucl Med Mol Imaging; 2021 Jul 01; 48(8):2657-2658. PubMed ID: 33661328
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.